Frequent vascular access thrombosis in a patient with end stage kidney disease on hemodialysis

This article reviews the association between hypercoagulability and VAT and the high prevalence of hypercoagulable states in end-stage kidney disease (ESKD). This article reviews the role of antithrombotic and anticoagulant medications in preventing VAT. The article concludes by reviewing the unique challenges of using vitamin K antagonists in patients with ESKD.PMID:37641427 | DOI:10.1111/sdi.13172
Source: Seminars in Dialysis - Category: Urology & Nephrology Authors: Source Type: research